Amivas is a pharmaceutical company dedicated to the development, commercialization, and distribution of Artesunate, a critical treatment for severe malaria. The company operates as a joint venture across the US, Australia, and Europe, with manufacturing facilities in North America and partnerships for packaging and distribution in Canada, the USA, and Europe. Artesunate has been recognized as the global standard of care for severe malaria for over two decades, with endorsements from health authorities such as the US CDC and FDA. The product is supplied as a sterile powder that can be easily prepared for use, making it a fast and effective option for treating severe malaria in both adults and children.

The company’s mission emphasizes its commitment to becoming a global leader in combating infectious diseases through scientific innovation and the provision of life-saving medicines. Artesunate is associated with a significant reduction in mortality risk compared to traditional treatments, and it is approved for use in multiple regions, including the US, EU, and UK. Amivas is actively involved in ensuring the availability of Artesunate, with plans for its launch in various markets, including the UK and EU, further solidifying its role in the global fight against malaria. The company also prioritizes safety and efficacy, providing comprehensive information for healthcare professionals regarding the use and potential side effects of Artesunate.

United States

Amivas (US), LLC is an Australian, Canadian, and US joint venture focused on the development, manufacturing, and commercialization of therapeutics for the treatment of infectious diseases.

Amivas (US), LLC was formed in response to the urgent need for a US -based firm to assume responsibility for the manufacture and distribution of Artesunate for Injection, for severe malaria after quinidine gluconate was discontinued by the manufacturer.

With FDA approval of its first commercial product, Amivas (US), LLC is proud to join the global effort to fight and eradicate malaria.

Amivas

Company Details